Skip to main content

Table 1 Descriptive statistics of the cohort stratified by secretor status and overall given as median [Q1; Q3] for HMO and mean (standard deviation) for the other continuous variables. Group differences were tested using Kruskal-Wallis-tests (HMO) and t-tests (other variables)

From: Concentrations of oligosaccharides in human milk and child growth

  Secretor (n = 124) Non-secretor (n = 21) p-value Total
n = 145
n (non-missing)
Maternal age (years) 30.3 (4.12) 30.2 (4.95) 0.898 30.3 (4.24) 143
Pre-pregnancy BMI (kg/m2) 23.2 (3.78) 22.7 (3.83) 0.642 23.2 (3.78) 124
Gestational age (months) 40.0 (1.15) 40.2 (1.26) 0.494 40.0 (1.16) 145
Birth weight (g) 3467 (473) 3646 (486) 0.13 3493 (477) 145
Birth length (cm) 50.3 (2.37) 50.7 (2.28) 0.475 50.4 (2.36) 144
Birth head circumference (cm) 34.9 (1.51) 35.3 (1.33) 0.301 35.0 (1.48) 123
HMO (mg/L)
 2‘FL 2038 [1536;2722] 7.37 [6.66;10.0] < 0.001 1931 [1317;2414] 145
 3-FL 785 [531;1114] 2544 [2007;2889] < 0.001 916 [565;1227] 145
 3′SL 136 [119;162] 160 [134;173] 0.026 138 [120;166] 145
 6′SL 151 [104;201] 139 [111;265] 0.39 150 [104;207] 145
 LNT 547 [353;720] 699 [545;934] 0.01 567 [361;764] 145
 LNnT 149 [117;200] 66.9 [38.8;89.9] < 0.001 137 [90.8;185] 145
 LNFP-I 473 [292;839] 2.00 [2.00;2.00] < 0.001 416 [196;789] 145
 LNFP-V 44.6 [31.3;61.9] 197 [141;235] < 0.001 50.1 [33.7;83.5] 145
 LNnFP 16.6 [9.51;22.7] 17.6 [7.56;21.6] 0.848 16.7 [8.82;22.7] 145
  1. BMI Body Mass Index, HMO Human Milk Oligosaccharide, 2’FL 2′-fucosyllactose, 3-FL 3-fucosyllactose, 3′SL 3′-sialyllactose, 6′SL 6′-sialyllactose, LNT lacto-N-tetraose, LNnT lacto-N-neotetraose, LNFP-I lacto-N-fucopentaose-I, LNFP-V lacto-N-fucopentaose-V, LNnFP lacto-N-neofucopentaose